Sodium in PDB 9ez6: Complex of A Mutant of the Sars-Cov-2 Main Protease Mpro with the NSP14/15 Substrate Peptide.
Protein crystallography data
The structure of Complex of A Mutant of the Sars-Cov-2 Main Protease Mpro with the NSP14/15 Substrate Peptide., PDB code: 9ez6
was solved by
R.Battistutta,
E.Fornasier,
G.Giachin,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
55.95 /
1.87
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
67.802,
99.032,
100.841,
90,
90,
90
|
R / Rfree (%)
|
19.5 /
22.8
|
Sodium Binding Sites:
The binding sites of Sodium atom in the Complex of A Mutant of the Sars-Cov-2 Main Protease Mpro with the NSP14/15 Substrate Peptide.
(pdb code 9ez6). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 2 binding sites of Sodium where determined in the
Complex of A Mutant of the Sars-Cov-2 Main Protease Mpro with the NSP14/15 Substrate Peptide., PDB code: 9ez6:
Jump to Sodium binding site number:
1;
2;
Sodium binding site 1 out
of 2 in 9ez6
Go back to
Sodium Binding Sites List in 9ez6
Sodium binding site 1 out
of 2 in the Complex of A Mutant of the Sars-Cov-2 Main Protease Mpro with the NSP14/15 Substrate Peptide.
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Complex of A Mutant of the Sars-Cov-2 Main Protease Mpro with the NSP14/15 Substrate Peptide. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na414
b:63.6
occ:1.00
|
OD1
|
A:ASP263
|
2.0
|
60.5
|
1.0
|
OD1
|
A:ASN221
|
2.0
|
64.5
|
1.0
|
O
|
A:PHE223
|
2.3
|
54.5
|
1.0
|
O
|
A:ASN221
|
2.3
|
55.2
|
1.0
|
O
|
A:HOH507
|
2.5
|
53.9
|
1.0
|
H
|
A:PHE223
|
3.0
|
69.7
|
1.0
|
O
|
A:ASP263
|
3.0
|
48.5
|
1.0
|
C
|
A:ASN221
|
3.1
|
60.6
|
1.0
|
H
|
A:ASN221
|
3.1
|
67.7
|
1.0
|
CG
|
A:ASP263
|
3.2
|
65.0
|
1.0
|
HB3
|
A:ALA266
|
3.2
|
66.3
|
1.0
|
CG
|
A:ASN221
|
3.2
|
48.0
|
1.0
|
N
|
A:PHE223
|
3.3
|
58.1
|
1.0
|
C
|
A:PHE223
|
3.4
|
56.6
|
1.0
|
HA
|
A:ASP263
|
3.6
|
60.9
|
1.0
|
C
|
A:ASP263
|
3.8
|
49.4
|
1.0
|
N
|
A:ASN221
|
3.8
|
56.4
|
1.0
|
CA
|
A:ASN221
|
3.9
|
56.2
|
1.0
|
CA
|
A:PHE223
|
3.9
|
57.1
|
1.0
|
C
|
A:ARG222
|
3.9
|
58.9
|
1.0
|
OD2
|
A:ASP263
|
3.9
|
61.8
|
1.0
|
N
|
A:ARG222
|
3.9
|
55.6
|
1.0
|
CA
|
A:ASP263
|
4.0
|
50.7
|
1.0
|
CB
|
A:ALA266
|
4.1
|
55.3
|
1.0
|
HB2
|
A:PHE223
|
4.1
|
73.9
|
1.0
|
CB
|
A:ASN221
|
4.1
|
56.3
|
1.0
|
CB
|
A:ASP263
|
4.2
|
51.2
|
1.0
|
HB1
|
A:ALA266
|
4.2
|
66.3
|
1.0
|
HA
|
A:ARG222
|
4.2
|
66.7
|
1.0
|
HD21
|
A:ASN221
|
4.2
|
71.6
|
1.0
|
ND2
|
A:ASN221
|
4.2
|
59.7
|
1.0
|
CA
|
A:ARG222
|
4.2
|
55.6
|
1.0
|
H
|
A:SER267
|
4.2
|
56.5
|
1.0
|
OG
|
A:SER267
|
4.3
|
54.7
|
1.0
|
HA
|
A:THR224
|
4.4
|
66.9
|
1.0
|
N
|
A:THR224
|
4.5
|
60.7
|
1.0
|
HB2
|
A:ALA266
|
4.6
|
66.3
|
1.0
|
CB
|
A:PHE223
|
4.6
|
61.6
|
1.0
|
HB2
|
A:ASN221
|
4.6
|
67.5
|
1.0
|
N
|
A:SER267
|
4.6
|
47.0
|
1.0
|
HG
|
A:SER267
|
4.6
|
65.6
|
1.0
|
HB2
|
A:ASP263
|
4.6
|
61.5
|
1.0
|
H
|
A:ARG222
|
4.6
|
66.7
|
1.0
|
O
|
A:ARG222
|
4.7
|
68.5
|
1.0
|
HA
|
A:PHE223
|
4.7
|
68.6
|
1.0
|
HA
|
A:ASN221
|
4.8
|
67.5
|
1.0
|
HB3
|
A:ASN221
|
4.9
|
67.5
|
1.0
|
HB3
|
A:ASP263
|
4.9
|
61.5
|
1.0
|
C
|
A:ALA266
|
5.0
|
47.9
|
1.0
|
N
|
A:MET264
|
5.0
|
43.7
|
1.0
|
|
Sodium binding site 2 out
of 2 in 9ez6
Go back to
Sodium Binding Sites List in 9ez6
Sodium binding site 2 out
of 2 in the Complex of A Mutant of the Sars-Cov-2 Main Protease Mpro with the NSP14/15 Substrate Peptide.
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Complex of A Mutant of the Sars-Cov-2 Main Protease Mpro with the NSP14/15 Substrate Peptide. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na405
b:59.0
occ:1.00
|
OD1
|
B:ASP263
|
2.0
|
64.9
|
1.0
|
OD1
|
B:ASN221
|
2.0
|
55.6
|
1.0
|
O
|
B:HOH504
|
2.3
|
49.2
|
1.0
|
O
|
B:ASP263
|
2.5
|
58.5
|
1.0
|
O
|
B:PHE223
|
2.6
|
53.8
|
1.0
|
HB3
|
B:ALA266
|
2.7
|
76.1
|
1.0
|
O
|
B:ASN221
|
2.7
|
56.2
|
1.0
|
H
|
B:ASN221
|
3.0
|
68.6
|
1.0
|
CG
|
B:ASN221
|
3.1
|
52.3
|
1.0
|
CG
|
B:ASP263
|
3.2
|
64.6
|
1.0
|
OG
|
B:SER267
|
3.3
|
63.9
|
1.0
|
C
|
B:ASP263
|
3.3
|
55.8
|
1.0
|
H
|
B:SER267
|
3.3
|
71.7
|
1.0
|
H
|
B:PHE223
|
3.4
|
64.1
|
1.0
|
HA
|
B:ASP263
|
3.4
|
64.3
|
1.0
|
C
|
B:ASN221
|
3.5
|
56.2
|
1.0
|
HG
|
B:SER267
|
3.6
|
76.6
|
1.0
|
CB
|
B:ALA266
|
3.7
|
63.4
|
1.0
|
C
|
B:PHE223
|
3.7
|
53.5
|
1.0
|
N
|
B:PHE223
|
3.8
|
53.4
|
1.0
|
CA
|
B:ASP263
|
3.8
|
53.5
|
1.0
|
N
|
B:ASN221
|
3.8
|
57.2
|
1.0
|
N
|
B:SER267
|
3.8
|
59.7
|
1.0
|
HD21
|
B:ASN221
|
3.8
|
68.2
|
1.0
|
HB1
|
B:ALA266
|
3.9
|
76.1
|
1.0
|
ND2
|
B:ASN221
|
3.9
|
56.8
|
1.0
|
CA
|
B:ASN221
|
4.0
|
55.9
|
1.0
|
OD2
|
B:ASP263
|
4.1
|
66.5
|
1.0
|
CB
|
B:ASP263
|
4.1
|
58.9
|
1.0
|
CB
|
B:ASN221
|
4.1
|
62.0
|
1.0
|
HB2
|
B:PHE223
|
4.2
|
66.4
|
1.0
|
HB2
|
B:ALA266
|
4.2
|
76.1
|
1.0
|
CA
|
B:PHE223
|
4.2
|
54.9
|
1.0
|
HA
|
B:MET264
|
4.4
|
63.9
|
1.0
|
C
|
B:ALA266
|
4.4
|
55.8
|
1.0
|
N
|
B:MET264
|
4.4
|
53.8
|
1.0
|
H
|
B:ALA266
|
4.4
|
68.0
|
1.0
|
CB
|
B:SER267
|
4.4
|
51.3
|
1.0
|
C
|
B:ARG222
|
4.4
|
54.0
|
1.0
|
N
|
B:ARG222
|
4.5
|
51.2
|
1.0
|
CA
|
B:ALA266
|
4.5
|
57.7
|
1.0
|
HA
|
B:SER267
|
4.5
|
65.8
|
1.0
|
CA
|
B:SER267
|
4.5
|
54.9
|
1.0
|
HA
|
B:THR224
|
4.6
|
67.2
|
1.0
|
HB3
|
B:ASP263
|
4.6
|
70.7
|
1.0
|
HA
|
B:LEU220
|
4.7
|
70.5
|
1.0
|
HB2
|
B:SER267
|
4.7
|
61.6
|
1.0
|
HB2
|
B:ASN221
|
4.7
|
74.4
|
1.0
|
HD22
|
B:ASN221
|
4.7
|
68.2
|
1.0
|
HB2
|
B:ASP263
|
4.7
|
70.7
|
1.0
|
HB3
|
B:ASN221
|
4.7
|
74.4
|
1.0
|
N
|
B:ALA266
|
4.7
|
56.6
|
1.0
|
CB
|
B:PHE223
|
4.8
|
55.3
|
1.0
|
N
|
B:THR224
|
4.8
|
55.1
|
1.0
|
CA
|
B:MET264
|
4.8
|
53.2
|
1.0
|
CA
|
B:ARG222
|
4.9
|
53.0
|
1.0
|
HA
|
B:ASN221
|
4.9
|
67.0
|
1.0
|
HA
|
B:ARG222
|
5.0
|
63.6
|
1.0
|
C
|
B:LEU220
|
5.0
|
51.8
|
1.0
|
|
Reference:
E.Fornasier,
S.Fabbian,
H.Shehi,
J.Enderle,
B.Gatto,
D.Volpin,
B.Biondi,
M.Bellanda,
G.Giachin,
A.Sosic,
R.Battistutta.
Allostery in Homodimeric Sars-Cov-2 Main Protease. Commun Biol V. 7 1435 2024.
ISSN: ESSN 2399-3642
PubMed: 39496839
DOI: 10.1038/S42003-024-07138-W
Page generated: Tue Feb 25 11:43:44 2025
|